Tianjin Tianyao Pharmaceuticals Co Ltd (600488) — Cash Flow Reinvestment Rate
Tianjin Tianyao Pharmaceuticals Co Ltd (600488) has a Cash Flow Reinvestment Rate of 1.33x as of September 2025, reinvesting CN¥17.49 Million (capex CN¥17.49 Million ) from operating cash flow of CN¥13.19 Million. Check Tianjin Tianyao Pharmaceuticals Co Ltd (600488) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tianjin Tianyao Pharmaceuticals Co Ltd Cash Flow Reinvestment Rate (2000–2024)
Historical reinvestment intensity for Tianjin Tianyao Pharmaceuticals Co Ltd across 23 annual periods. Explore 600488 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Tianjin Tianyao Pharmaceuticals Co Ltd (2000–2024)
Year-by-year capital reinvestment analysis for Tianjin Tianyao Pharmaceuticals Co Ltd. For live market cap and broader valuation context, see how much is Tianjin Tianyao Pharmaceuticals Co Ltd worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.27x | CN¥153.93 Million | CN¥569.37 Million | CN¥77.74 Million | ▲ +59.0% |
| 2023 | 0.17x | CN¥133.15 Million | CN¥783.01 Million | CN¥133.15 Million | ▼ -72.2% |
| 2022 | 0.61x | CN¥400.33 Million | CN¥653.52 Million | CN¥202.20 Million | ▼ -74.0% |
| 2021 | 2.36x | CN¥747.80 Million | CN¥316.89 Million | CN¥370.84 Million | ▼ -21.5% |
| 2020 | 3.01x | CN¥1.04 Billion | CN¥346.88 Million | CN¥458.51 Million | ▲ +200.2% |
| 2019 | 1.00x | CN¥279.74 Million | CN¥279.37 Million | CN¥279.04 Million | ▼ -7.0% |
| 2018 | 1.08x | CN¥203.88 Million | CN¥189.27 Million | CN¥203.58 Million | ▼ -68.2% |
| 2016 | 3.39x | CN¥214.78 Million | CN¥63.32 Million | CN¥64.78 Million | ▲ +125.9% |
| 2015 | 1.50x | CN¥194.48 Million | CN¥129.50 Million | CN¥45.32 Million | ▲ +1499.9% |
| 2014 | 0.09x | CN¥16.78 Million | CN¥178.76 Million | CN¥16.78 Million | ▼ -97.4% |
| 2013 | 3.67x | CN¥310.08 Million | CN¥84.55 Million | CN¥310.08 Million | ▼ -35.8% |
| 2012 | 5.71x | CN¥75.59 Million | CN¥13.23 Million | CN¥75.59 Million | ▲ +614.5% |
| 2011 | 0.80x | CN¥62.76 Million | CN¥78.47 Million | CN¥62.76 Million | ▼ -36.8% |
| 2010 | 1.26x | CN¥147.76 Million | CN¥116.82 Million | CN¥147.76 Million | ▲ +172.0% |
| 2009 | 0.46x | CN¥202.32 Million | CN¥435.13 Million | CN¥202.32 Million | ▼ -71.5% |
| 2008 | 1.63x | CN¥357.63 Million | CN¥219.31 Million | CN¥357.63 Million | ▲ +17.8% |
| 2007 | 1.38x | CN¥224.74 Million | CN¥162.33 Million | CN¥224.74 Million | ▼ -1.0% |
| 2006 | 1.40x | CN¥70.91 Million | CN¥50.72 Million | CN¥70.91 Million | ▲ +15.5% |
| 2004 | 1.21x | CN¥133.47 Million | CN¥110.30 Million | CN¥133.47 Million | ▼ -68.2% |
| 2003 | 3.81x | CN¥174.24 Million | CN¥45.77 Million | CN¥174.24 Million | ▲ +0.7% |
| 2002 | 3.78x | CN¥171.20 Million | CN¥45.28 Million | CN¥171.20 Million | ▲ +459.5% |
| 2001 | 0.68x | CN¥48.57 Million | CN¥71.87 Million | CN¥48.57 Million | ▼ -23.5% |
| 2000 | 0.88x | CN¥36.29 Million | CN¥41.06 Million | CN¥36.29 Million | — |